<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04945629</url>
  </required_header>
  <id_info>
    <org_study_id>BTIIMD_01_EC/20/Molares</org_study_id>
    <nct_id>NCT04945629</nct_id>
  </id_info>
  <brief_title>Plasma Rich in Growth Factors in the Preservation of the Alveolar Ridge After Simple Molar Tooth Extractions.</brief_title>
  <official_title>Randomized Clinical Trial, Controlled by Conventional Treatment, of Plasma Rich in Growth Factors (PRGF®) in the Preservation of the Alveolar Ridge After Simple Molar Tooth Extractions.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Eduardo Anitua</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Eduardo Anitua</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Randomized Clinical Trial aims to study the efficacy and safety of PRGF-Endoret in&#xD;
      alveolar ridge preservation after single molar extractions. The control group is the&#xD;
      spontaneous healing occuring after the suturing of the alveolus. The primary endpoint is the&#xD;
      bone regeneration measured in biopsies obtained from the regenerated alveolar bone.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone regeneration</measure>
    <time_frame>12 weeks post-extraction</time_frame>
    <description>Quantity of new bone measured in bone biopsies obtained after alveolar ridge preservation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Score (VAS)</measure>
    <time_frame>3, 7 and 15 days post-extraction</time_frame>
    <description>Evolution of pain assessed by the visual analog scale (VAS). Values ranging 0 to 10 (0=no pain and 10=worst pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation score</measure>
    <time_frame>3, 7 and 15 days post-extraction</time_frame>
    <description>Evolution of inflammation evaluated by ordinal scale from 0 to 3 (0=no inflammation; 3=severe inflammation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Soft tissue healing index</measure>
    <time_frame>3, 7 and 15 days post-extraction</time_frame>
    <description>Soft tissue healing index according to the scale of Laundry. Values ranging 1 to 5 (1=poor healing, 5=excellent healing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the dimension of the alveolar ridge</measure>
    <time_frame>12 weeks post-extraction</time_frame>
    <description>Changes in the dimension of the alveolar ridge by means of superimposition of digital files of models of plaster after 12 weeks post-extraction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Soft tissue histomorphometric changes</measure>
    <time_frame>12 weeks post-extraction</time_frame>
    <description>- Soft tissue histomorphometric changes after evaluated by soft tissue biopsy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the bone dimensions of the alveolar ridge</measure>
    <time_frame>12 weeks post-extraction</time_frame>
    <description>Change in the bone dimensions of the alveolar ridge evaluated by CBCT between the post-extraction day and the week 12 post-extraction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in bone density</measure>
    <time_frame>12 weeks post-extraction</time_frame>
    <description>Change in bone density (Hounsfield units) evaluated by the CBCT at three different points between the post-extraction week and 12 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D levels</measure>
    <time_frame>12 weeks post-extraction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of surgical and postsurgical complications</measure>
    <time_frame>12 weeks post-extraction</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Dental Implantation</condition>
  <arm_group>
    <arm_group_label>Simple suture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Atraumatic exodontia followed by simple suture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PRGF-Endoret</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Atraumatic exodontia followed by simple suture</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alveolar ridge preservation with a PRP (PRGF-Endoret)</intervention_name>
    <description>Filling of the alveolus with PRGF clot and fibrin plug.</description>
    <arm_group_label>PRGF-Endoret</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Blood clot and simple suture</intervention_name>
    <description>Filling the alveolus with blood clot</description>
    <arm_group_label>Simple suture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age&gt; 18 years&#xD;
&#xD;
          -  Clinical indication for simple tooth extraction in the posterior sectors (from the&#xD;
             second premolar to upper and lower second molars)&#xD;
&#xD;
          -  Need to place a dental implant in the same position of the extraction&#xD;
&#xD;
          -  Availability of observation during the period of treatment&#xD;
&#xD;
          -  Signature of the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Third molars&#xD;
&#xD;
          -  Active periodontal disease&#xD;
&#xD;
          -  Simultaneous extraction of two adjacent pieces in the same quadrant&#xD;
&#xD;
          -  Oral dehiscence ≥ 25%&#xD;
&#xD;
          -  Alveolus depth &lt;7mm&#xD;
&#xD;
          -  Loss of some wall of the alveolus&#xD;
&#xD;
          -  Severe inflammation in the extraction area&#xD;
&#xD;
          -  Previous diagnosis of coagulopathies&#xD;
&#xD;
          -  Previous diagnosis of autoimmune disease&#xD;
&#xD;
          -  Be receiving, or have received the 30 days prior to extraction treatment with&#xD;
             radiotherapy, chemotherapy, immunosuppressants, systemic corticosteroids or&#xD;
             anticoagulants&#xD;
&#xD;
          -  Regular treatment with NSAIDs&#xD;
&#xD;
          -  History of chronic hepatitis or liver cirrhosis&#xD;
&#xD;
          -  Positive markers for HCV, AfHBs, HIV-I / II or TP&#xD;
&#xD;
          -  Diabetes mellitus with poor metabolic control (evidence of glycated hemoglobin&gt; 9%)&#xD;
&#xD;
          -  Dialysis treatment&#xD;
&#xD;
          -  Presence of malignant tumors, hemangiomas or angioma in the extraction area.&#xD;
&#xD;
          -  History of ischemic heart disease in the last year&#xD;
&#xD;
          -  Pregnancy or women of childbearing age who do not take action contraceptives&#xD;
&#xD;
          -  Lactating women&#xD;
&#xD;
          -  Previous diagnosis of metabolic bone disease&#xD;
&#xD;
          -  Antiresorptive treatment&#xD;
&#xD;
          -  Treatment with monoclonal antibodies&#xD;
&#xD;
          -  Smoker&gt; 10 cigarettes / day&#xD;
&#xD;
          -  Any inability to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mikel Allende, PhD</last_name>
    <phone>+34945160653</phone>
    <phone_ext>257</phone_ext>
    <email>mikel.allende@bti-implant.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinica Eduardo Anitua</name>
      <address>
        <city>Vitoria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikel Allende</last_name>
      <phone>+34945160653</phone>
      <email>mikel.allende@bti-implant.es</email>
    </contact>
    <investigator>
      <last_name>Eduardo Anitua, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adriana Montalvillo, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 15, 2021</study_first_submitted>
  <study_first_submitted_qc>June 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2021</study_first_posted>
  <last_update_submitted>June 22, 2021</last_update_submitted>
  <last_update_submitted_qc>June 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>exodontia</keyword>
  <keyword>PRGF</keyword>
  <keyword>Alveolar Ridge preservation</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

